{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:48:47Z","timestamp":1790477327875,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sigrid Juselius Foundation"},{"name":"Reino Lahtikari Foundation"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jcv.2020.104334","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T07:35:35Z","timestamp":1587972935000},"page":"104334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Eradication of persistent coxsackievirus B infection from a pancreatic cell line with clinically used antiviral drugs"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-1025","authenticated-orcid":false,"given":"Anni","family":"Honkimaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5538-5153","authenticated-orcid":false,"given":"Amir-Babak","family":"Sioofy-Khojine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Oikarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-2074","authenticated-orcid":false,"given":"Didier","family":"Hober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Hy\u00f6ty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2020.104334_bib0005","first-page":"43","article-title":"Picornaviruses","volume":"343","author":"Tuthill","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jcv.2020.104334_bib0010","series-title":"Fields Virology","first-page":"490","article-title":"Enteroviruses: polioviruses, coxsakieviruses, echoviruses, and newer enteroviruses","author":"Pallansch","year":"2013"},{"key":"10.1016\/j.jcv.2020.104334_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1900\/RDS.2012.9.260","article-title":"Virus infections as potential targets of preventive treatments for type 1 diabetes","volume":"9","author":"Nurminen","year":"2012","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.jcv.2020.104334_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/ann.34.3.138.147","article-title":"Enterovirus infections and type 1 diabetes","volume":"34","author":"Hyoty","year":"2002","journal-title":"Ann. Med."},{"key":"10.1016\/j.jcv.2020.104334_bib0025","first-page":"275","article-title":"Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy","volume":"323","author":"Chapman","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jcv.2020.104334_bib0030","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/jcp.2004.020255","article-title":"The role of enterovirus in chronic fatigue syndrome","volume":"58","author":"Chia","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2020.104334_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijid.2015.04.018","article-title":"Post-poliomyelitis syndrome as a possible viral disease","volume":"35","author":"Baj","year":"2015","journal-title":"Int. J. Infect. Dis."},{"issue":"Suppl 22","key":"10.1016\/j.jcv.2020.104334_bib0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/pedi.12370","article-title":"Viruses in type 1 diabetes","volume":"17","author":"Hyoty","year":"2016","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.jcv.2020.104334_bib0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","article-title":"Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes","volume":"61","author":"Sioofy-Khojine","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcv.2020.104334_bib0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/db13-0619","article-title":"Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes","volume":"63","author":"Laitinen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jcv.2020.104334_bib0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2337\/db13-0620","article-title":"Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes","volume":"63","author":"Oikarinen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jcv.2020.104334_bib0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.diabet.2008.05.008","article-title":"Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes","volume":"34","author":"Jaidane","year":"2008","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.jcv.2020.104334_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/rmv.647","article-title":"Enteroviruses and type 1 diabetes: towards a better understanding of the relationship","volume":"20","author":"Jaidane","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0070","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jmv.10236","article-title":"Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology","volume":"68","author":"Yin","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.326","article-title":"The group B coxsackieviruses and myocarditis","volume":"11","author":"Kim","year":"2001","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0080","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1128\/JVI.79.11.7024-7041.2005","article-title":"5\u2019-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA","volume":"79","author":"Kim","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0085","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1128\/JVI.01774-07","article-title":"Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions","volume":"82","author":"Kim","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0090","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/jmv.23903","article-title":"Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity","volume":"86","author":"Hamalainen","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0095","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1007\/s00018-013-1383-4","article-title":"Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates","volume":"70","author":"Sane","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jcv.2020.104334_bib0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcv.2012.11.018","article-title":"Human enterovirus 71 strains in the background population and in hospital patients in Finland","volume":"56","author":"Honkanen","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.isci.2019.07.040","article-title":"Coxsackievirus B persistence modifies the proteome and the secretome of pancreatic ductal cells","volume":"19","author":"Lietzen","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.jcv.2020.104334_bib0110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jcv.2020.104334_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2003.11.001","article-title":"Synergistic drug combinations against the in vitro replication of Coxsackie B1 virus","volume":"62","author":"Nikolaeva-Glomb","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104334_bib0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104334_bib0125","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/AAC.00983-12","article-title":"Fluoxetine is a potent inhibitor of coxsackievirus replication","volume":"56","author":"Zuo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104334_bib0130","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.05108-14","article-title":"Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104334_bib0135","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1128\/JVI.05712-11","article-title":"Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis","volume":"86","author":"Graci","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00011-013-0695-z","article-title":"Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells","volume":"63","author":"Werner","year":"2014","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jcv.2020.104334_bib0145","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104334_bib0150","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2014.12.054","article-title":"Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein","volume":"10","author":"Strating","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jcv.2020.104334_bib0155","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/cr.2012.129","article-title":"Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication","volume":"22","author":"van der Schaar","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.jcv.2020.104334_bib0160","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2020.104334_bib0165","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/09031936.00102014","article-title":"Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells","volume":"45","author":"Schogler","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jcv.2020.104334_bib0170","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cell.2010.03.050","article-title":"Viral reorganization of the secretory pathway generates distinct organelles for RNA replication","volume":"141","author":"Hsu","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2020.104334_bib0175","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/AAC.02084-12","article-title":"Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C","volume":"57","author":"Ulferts","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104334_bib0180","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/AAC.02182-15","article-title":"Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C","volume":"60","author":"Ulferts","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104334_bib0185","article-title":"A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses","author":"Sioofy-Khojine","year":"2019","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jcv.2020.104334_bib0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41598-017-18495-4","article-title":"A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses","volume":"8","author":"Saarinen NVV","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2020.104334_bib0195","doi-asserted-by":"crossref","first-page":"13409","DOI":"10.1128\/JVI.00621-11","article-title":"Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line","volume":"85","author":"Pinkert","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0200","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/21505594.2017.1284735","article-title":"Persistence of coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes","volume":"8","author":"Alidjinou","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.jcv.2020.104334_bib0205","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dki263","article-title":"Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment","volume":"56","author":"Schmidtke","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2020.104334_bib0210","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.43.3.634","article-title":"Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Pediatric pharmacology research unit network","volume":"43","author":"Kearns","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104334_bib0215","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(02)00277-3","article-title":"FDA panel rejects common cold treatment","volume":"2","author":"Senior","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2020.104334_bib0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jpids\/piv015","article-title":"A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus Sepsis","volume":"5","author":"Abzug","year":"2016","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"10.1016\/j.jcv.2020.104334_bib0225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmv.21980","article-title":"Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin","volume":"83","author":"Planitzer","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2020.104334_bib0230","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00006454-198311000-00009","article-title":"Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin","volume":"2","author":"Dagan","year":"1983","journal-title":"Pediatr. Infect. Dis."},{"key":"10.1016\/j.jcv.2020.104334_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2015.01.010","article-title":"Persistent infection of human pancreatic cells with coxsackievirus B4 is cured by fluoxetine","volume":"116","author":"Alidjinou","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104334_bib0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2018.10.002","article-title":"Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo","volume":"159","author":"Benkahla","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104334_bib0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1570-0232(02)00486-5","article-title":"Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients","volume":"783","author":"LLerena","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jcv.2020.104334_bib0250","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00004714-200212000-00006","article-title":"Fluoxetine pharmacokinetics in pediatric patients","volume":"22","author":"Wilens","year":"2002","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220300767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220300767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:13:42Z","timestamp":1761362022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653220300767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":50,"alternative-id":["S1386653220300767"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104334","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of persistent coxsackievirus B infection from a pancreatic cell line with clinically used antiviral drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104334"}}